Bioventus (BVS) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by June 2, 2026, at 11:59 PM ET.

Voting matters and shareholder proposals

• Election of 12 director nominees to serve until the 2027 annual meeting and until successors are elected and qualified.

• Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Board recommends voting FOR all director nominees and FOR the auditor ratification.

• Other business may be addressed if properly brought before the meeting.

Board of directors and corporate governance

• Director nominees include William A. Hawkins, John A. Bartholdson, Patrick J. Beyer, Robert E. Claypoole, Philip G. Cowdy, Ajay Dhankhar, Mary Kay Ladone, Michelle McMurry-Heath, Guido J. Neels, Guy P. Nohra, Susan M. Stalnecker, and Martin P. Sutter.